[1]
|
Lawler, J., Duquette, M., Whittaker, C.A., et al. (1993) Identification and Characterization of Thrombospondin-4, a New Member of the Thrombospondin Gene Family. Journal of Cell Biology, 120, 1059-1067.
https://doi.org/10.1083/jcb.120.4.1059
|
[2]
|
Liu, J., Cheng, G., Yang, H., et al. (2016) Reciprocal Regulation of Long Noncoding RNAs THBS4-003 and THBS4 Control Migration and Invasion in Prostate Cancer Cell Lines. Molecular Medicine Reports, 14, 1451-1458.
https://doi.org/10.3892/mmr.2016.5443
|
[3]
|
Lawler, J., McHenry, K., Duquette, M., et al. (1995) Characterization of Human Thrombospondin-4. Journal of Biological Chemistry, 270, 2809-2814. https://doi.org/10.1074/jbc.270.6.2809
|
[4]
|
Tucker, R.P., Adams, J.C. and Lawler, J. (1995) Thrombospondin-4 Is Expressed by Early Osteogenic Tissues in the Chick Embryo. Developmental Dynamics, 203, 477-490. https://doi.org/10.1002/aja.1002030410
|
[5]
|
Lee, J.H., Horak, C.E., Khanna, C., et al. (2008) Alterations in Gemin5 Expression Contribute to Alternative mRNA Splicing Patterns and Tumor Cell Motility. Cancer Research, 68, 639-644.
https://doi.org/10.1158/0008-5472.CAN-07-2632
|
[6]
|
Stenina-Adognravi, O. and Plow, E.F. (2019) Thrombospondin-4 in Tissue Remodeling. Matrix Biology, 75-76, 300-313.
https://doi.org/10.1016/j.matbio.2017.11.006
|
[7]
|
Lavrador, J.P., et al. (2017) Adult Pilocytic Astrocytoma of Conus Medullaris: Clinical Considerations and Review of the Literature. CNS Oncology, 6, 107-110. https://doi.org/10.2217/cns-2016-0030
|
[8]
|
Rorive, S., Maris, C., Debeir, O., et al. (2006) Exploring the Distinctive Biological Characteristics of Pilocytic and Low-Grade Diffuse Astrocytomas Using Microarray Gene Expression Profiles. Journal of Neuropathology & Experimental Neurology, 65, 794-807. https://doi.org/10.1097/01.jnen.0000228203.12292.a1
|
[9]
|
Yang, H.J., Ma, S.P., Ju, F., et al. (2016) Thrombospondin-4 Promotes Neuronal Differentiation of NG2 Cells via the ERK/MAPK Pathway. Journal of Molecular Neuroscience, 60, 517-524. https://doi.org/10.1007/s12031-016-0845-1
|
[10]
|
Park, B.L., Kim, Y.J., Cheong, H.S., et al. (2006) Association of Common Promoter Polymorphisms of MCP1 with Hepatitis B Virus Clearance. Experimental & Molecular Medicine, 38, 694-702. https://doi.org/10.1038/emm.2006.82
|
[11]
|
Su, F., Zhao, J., Qin, S., et al. (2017) Over-Expression of Thrombospondin 4 Correlates with Loss of miR-142 and Contributes to Migration and Vascular Invasion of Advanced Hepatocellular Carcinoma. Oncotarget, 8, 23277-23288.
https://doi.org/10.18632/oncotarget.15054
|
[12]
|
Wu, H., Zhang, G., Li, Z., et al. (2019) Thrombospondin-4 Expression as a Prognostic Marker in Hepatocellular Carcinoma. Gene, 696, 219-224. https://doi.org/10.1016/j.gene.2019.02.049
|
[13]
|
Forster, S., Gretschel, S., Jons, T., et al. (2011) THBS4, a Novel Stromal Molecule of Diffuse-Type Gastric Adenocarcinomas, Identified by Transcriptome-Wide Expression Profiling. Modern Pathology, 24, 1390-1403.
https://doi.org/10.1038/modpathol.2011.99
|
[14]
|
Maran, S., Lee, Y.Y., Xu, S., et al. (2013) Gastric Precancerous Lesions Are Associated with Gene Variants in Helicobacter pylori-Susceptible Ethnic Malays. World Journal of Gastroenterology, 19, 3615-3622.
https://doi.org/10.3748/wjg.v19.i23.3615
|
[15]
|
Lin, X., Hu, D., Chen, G., et al. (2016) Associations of THBS2 and THBS4 Polymorphisms to Gastric Cancer in a Southeast Chinese Population. Cancer Genetics, 209, 215-222. https://doi.org/10.1016/j.cancergen.2016.04.003
|
[16]
|
Huang, T., Liu, D., Wang, Y., et al. (2018) FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway. 1421-9778 (Electronic). https://doi.org/10.1159/000494590
|
[17]
|
Chen, X., Huang, Y., Wang, Y., et al. (2019) THBS4 Predicts Poor Outcomes and Promotes Proliferation and Metastasis in Gastric Cancer. Journal of Physiology and Biochemistry, 75, 117-123.
https://doi.org/10.1007/s13105-019-00665-9
|
[18]
|
Kuroda, K., Yashiro, M., Sera, T., et al. (2019) The Clinicopathological Significance of Thrombospondin-4 Expression in the Tumor Microenvironment of Gastric Cancer. PLoS ONE, 14, e0224727.
https://doi.org/10.1371/journal.pone.0224727
|
[19]
|
Ding, Y., Chen, Y., Wu, M., et al. (2020) Identification of Genes Associated with Gastric Cancer Survival and Construction of a Nomogram to Improve Risk Stratification for Patients with Gastric Cancer. Oncology Letters, 20, 215-225. https://doi.org/10.3892/ol.2020.11543
|
[20]
|
Greco, S.A., Chia, J., Inglis, K.J., et al. (2010) Thrombospondin-4 Is a Putative Tumour-Suppressor Gene in Colorectal Cancer That Exhibits Age-Related Methylation. BMC Cancer, 10, 494. https://doi.org/10.1186/1471-2407-10-494
|
[21]
|
Kondo, Y., Shen, L., Yan, P.S., et al. (2004) Chromatin Immunoprecipitation Microarrays for Identification of Genes Silenced by Histone H3 Lysine 9 Methylation. Proceedings of the National Academy of Sciences of the United States of America, 101, 7398-7403. https://doi.org/10.1073/pnas.0306641101
|
[22]
|
Turashvili, G., Bouchal, J., Burkadze, G., et al. (2005) Differentiation of Tumours of Ductal and Lobular Origin: II. Genomics of Invasive Ductal and Lobular Breast Carcinomas. Biomedical Papers, 149, 63-68.
https://doi.org/10.5507/bp.2005.006
|
[23]
|
Korkola, J.E., DeVries, S., Fridlyand, J., et al. (2003) Differentiation of Lobular versus Ductal Breast Carcinomas by Expression Microarray Analysis. Cancer Research, 63, 7167-7175.
|
[24]
|
McCart Reed, A.E., Song, S., Kutasovic, J.R., et al. (2013) Thrombospondin-4 Expression Is Activated during the Stromal Response to Invasive Breast Cancer. Virchows Archiv, 463, 535-545.
https://doi.org/10.1007/s00428-013-1468-3
|
[25]
|
Tveitarås, M.K., Selheim, F., Sortland, K., et al. (2019) Protein Expression Profiling of Plasma and Lungs at Different Stages of Metastatic Development in a Human Triple Negative Breast Cancer Xenograft Model. PLoS ONE, 14, e0215909. https://doi.org/10.1371/journal.pone.0215909
|
[26]
|
Luo, J., Dunn, T., Ewing, C., et al. (2002) Gene Expression Signature of Benign Prostatic Hyperplasia Revealed by cDNA Microarray Analysis. Prostate, 51, 189-200. https://doi.org/10.1002/pros.10087
|
[27]
|
Dakhova, O., Ozen, M., Creighton, C.J., et al. (2009) Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer. Clinical Cancer Research, 15, 3979-3989. https://doi.org/10.1158/1078-0432.CCR-08-1899
|
[28]
|
Muppala, S., Xiao, R., Krukovets, I., et al. (2017) Thrombospondin-4 Mediates TGF-β-Induced Angiogenesis. Oncogene, 36, 5189-5198. https://doi.org/10.1038/onc.2017.140
|
[29]
|
Wu, J.H., Li, X.M., Luo, F., et al. (2020) Screening Key miRNAs and Genes in Prostate Cancer by Microarry Analysis. Transplantation Proceedings, 9, 856-868. https://doi.org/10.21037/tcr.2019.12.30
|
[30]
|
Sugimura, J., Yang, X.J., Tretiakova, M.S., et al. (2004) Gene Expression Profiling of Mesoblastic Nephroma and Wilms Tumors—Comparison and Clinical Implications. Urology, 64, 362-368.
https://doi.org/10.1016/j.urology.2004.04.052
|
[31]
|
Myers, T., Chengedza, S., Lightfoot, S., et al. (2009) Flexible Heteroarotinoid (Flex-Het) SHetA2 Inhibits Angiogenesis in Vitro and in Vivo. Investigational New Drugs, 27, 304-318. https://doi.org/10.1007/s10637-008-9175-7
|
[32]
|
van Doorn, R., Zoutman, W.H., Dijkman, R., et al. (2005) Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73. Journal of Clinical Oncology, 23, 3886-3896. https://doi.org/10.1200/JCO.2005.11.353
|